The NHS CB has published on a public website papers for its board meeting on the 2nd February. You can find them here:
http://www.commissioningboard.nhs.uk/2012/01/26/board-meeting-020212/
The papers cover a number of areas relevant for CCGs, in particular: Organisational Design of the NHSCB; Governance for CCGs; Authorisation of CCGs; and Commissioning Support. The only wholly new paper is the one on the Organisational Design of the NHSCB. The CCG Governance paper was produced in draft last year and while it has been updated contains only minor changes. The CCG Authorisation paper was produced in September last year, and the Commissioning Support paper has been available in draft since December last year. Most of what is ‘new’ appears in the covering papers, and for those who do not have a spare half day to read through everything our advice would be to concentrate your efforts there.
Key messages for CCGs
What CCGs are really looking for out of the Organisational Design paper is what it means in terms of how they are going to be managed. Some of the answers are starting to emerge. There will be local offices of the NHS CB that outside of London map more or less to the existing PCT Clusters. Each will have a local office director, a medical lead responsible for direct commissioning, a head of finance responsible for CCG assurance and a nursing lead. According to the Health Service Journal (26/01/12 p4) Bill McCarthy, NHS CB Managing Director has, ‘urged PCT Cluster Chief Executives to consider becoming Director of their local board office’. So now we know that there is a high probability that the current PCT Cluster CEOs will have the main responsibility for performance managing CCGs, and that they will do that through their Head of Finance (?existing Cluster Director of Finance) and a team of about 10 staff dedicated to ‘CCG assurance’.
So what does this mean for CCGs today? It means maintain positive relationships with your PCT Cluster CEO, Director of Finance and Director, Medical Director and Director of Nursing, because many may not be going anywhere fast. As we move into ‘shadow running’ next year they will be taking on the NHS CB role of ‘providing development support, and monitoring performance and outcomes’. Expect them to have a significant role in the authorisation process!
The other take away message is the strong emphasis there is going to be on the Commissioning Outcomes Framework. PCTs were not set up to drive outcomes in the way that CCGs will be expected to. CCGs need to be considering how they will establish their infrastructure to ensure they are driving improvements in outcomes. Quality leads will need to take on a dual responsibility for improving outcomes as well as quality assurance. CCGs need to be framing the support they will be receiving from public health in terms of the Commissioning Outcomes Framework, and ensuring they are driving the way the Health and Wellbeing strategy is being shaped locally to reflect this.
The most noteworthy fact about the governance document is the gap that exists between the governance requirements of CCGs, and the governance documentation that CCGs are currently putting together. Many CCGs claim to have a constitution signed by all member practices, but the reality is these will need tearing up and starting all over again. The failure to produce a model constitution by the NHS CB to date (it was initially promised by the end of December) I suspect will come back to haunt them, because CCGs are in for a shock when they see it, and it will be a significant challenge for these to be ready in time for authorisation.
The new information about authorisation appears in the covering paper. There will be two phases to authorisation. The first pre-assessment phase will be run by the existing SHA Cluster. The previous outline of further authorisation gateways to include governance in January and leadership in March has been changed to the production of ‘development checklists’ covering configuration, governance, leadership, commissioning support, planning and core infrastructure. This appears to be a moveable feast, so expect regional variation and more changes to come in this area. The second phase is formal assessment by the NHS CB. Applications will be in 4 tranches, with the first in July (completing in October) and the last in October (completing in January). It does not take a genius to work out that if 220 authorisations are to be completed start to finish in 6 months the majority of the process will have to be carried out by the existing PCT Clusters. A big question for CCGs is whether there is any benefit in going in an early tranche, or whether they would be better learning from those brave (daft) enough to go first. Expect CCGs to start fighting to be part of tranche 4 rather than tranche 1.
The Commissioning Support documentation is the one released at the end of 2011. The interesting expectation is that CCGs will have at least shadow SLA arrangements in from April 2012. A big call for CCGs is do they push for very detailed specifications (which push a ‘work to contract’ mentality and create arguments when work is required by the CCG that has not been specified) or very loose specifications (which create arguments because of differing levels of expectations on the two sides as to what will be provided). It seems there is very little time for CCGs and commissioning support organisations to work this through and get the balance right.
Recent Comments